Hints and tips:
Related Special Reports
...WPP’s Ogilvy advertising agency is creating a division specialising in online “health influencers” to help pharmaceutical companies tap a trend towards personalised health and combat misinformation....
...Health authorities had also hoped it could help sway sceptics who preferred not to receive an mRNA vaccine, though demand has since collapsed....
...Many Chinese viewers preferred a 2023 Chinese TV adaptation by tech giant Tencent that was set largely in China with predominantly Chinese actors....
...Modified domestic demand, the ministry’s preferred measure, was flat in the third quarter....
...The case is the latest in a series of intellectual property battles that companies are fighting around the world over mRNA technology, which has helped generate billions in revenues for the pharmaceuticals...
A company launched in 1963 confronts challenge of adapting to the rise of anti-obesity injections
...“It was one of the most epic episodes ever in pharmaceuticals history: you got an accelerated approval of a product that didn’t have a completed phase 3 trial....
US healthcare company is putting cash to work from spinning off its consumer health arm
Shah Capital wants change in US biotech’s strategy as its shares have tumbled since their pandemic peak
...Avid Bioservices, a small-cap company that helps develop and manufacture drugs for pharmaceutical companies, filed this with the SEC yesterday: On February 29, 2024, Avid Bioservices, Inc....
A weight loss titan fights to stay relevant in the age of GLP-1 drugs
Advocate general of bloc’s top court says decision against world’s biggest gene sequencing group should be annulled
...The FT later reported that Apollo’s offer was also rejected by Redstone, who has long preferred an arrangement with Ellison....
...Pharmaceuticals groups Pfizer and Moderna, which have both faced criticism from fringe groups over their Covid-19 vaccines, also spent heavily on security for their CEOs last year....
...said Jaret Seiberg, an analyst at brokerage TD Cowen, who added that the settlement could represent a threat to credit card rewards and small banks as merchants gained the ability to steer customers to preferred...
...A version of this article was first published by Nikkei Asia on April 2 2024. ©2024 Nikkei Inc. All rights reserved....
...The Medicines and Healthcare products Regulatory Agency has approved the therapy, called Casgevy, which was developed by Vertex Pharmaceuticals and Crispr Therapeutics....
...Despite splashing out nearly $55bn on two major acquisitions over the past two years, the pharmaceutical company is worth less than it was before the pandemic....
US drugmaker is trying to chart its future without blockbuster Covid-19 products
Millions of Paxlovid pills have gone unused as tight controls restrict access
...Many renters, meanwhile, still preferred traditional cars and hybrids, leaving Hertz car lots full with Teslas even after it offered drivers heavy discounts....
...Rival pharmaceutical groups are eager to enter the market, including AstraZeneca, which recently signed a licensing deal with Chinese company Eccogene for the rights to its weight loss pill....
...They would have preferred a transaction with Cleveland-Cliffs....
...Unlike a sale of a company or a liquidation, a stock market listing converts all preferred stock held by a business’s venture investors to the same common stock held by employees and management, extinguishing...
...The investor group will purchase NYCB’s common stock at a price of $2 per share and convertible preferred stock at the same conversion price, according to a press release....
International Edition